Trulieve Cannabis (TCNNF) Liabilities from Discontinued Operations (2021 - 2026)
Trulieve Cannabis (TCNNF) recorded quarterly Liabilities from Discontinued Operations of 3802000.0 in Q1 2026, down 89.12% quarter-over-quarter from 34942000.0 in Q4 2025, and down 89.92% on a YoY basis from 37703000.0 in Q1 2025.
Trulieve Cannabis (TCNNF) Liabilities from Discontinued Operations (2021 - 2026) Analysis & Trends
Trulieve Cannabis' Liabilities from Discontinued Operations history runs 6 years deep, the most recent figure standing at 3802000.0 for Q1 2026.
- In Q1 2026, Liabilities from Discontinued Operations fell 89.92% year-over-year to 3802000.0; the TTM figure through Mar 2026 stood at 3802000.0 (down 89.92% YoY), while the FY2025 annual figure was 34942000.0, up 1016.71% from the prior year.
- Liabilities from Discontinued Operations was 3802000.0 for Q1 2026 at Trulieve Cannabis, down from 34942000.0 in the prior quarter.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of 41553000.0 in Q4 2023 to a low of 35000.0 in Q1 2023.
- Historically, Liabilities from Discontinued Operations has averaged 16667666.67 across 5 years, with a median of 3455000.0 in 2024.
- Biggest YoY gain for Liabilities from Discontinued Operations was 8617.14% in 2024; the steepest drop was 92.47% in 2024.
- A 5-year view of Liabilities from Discontinued Operations shows it stood at 2328000.0 in 2022, then soared by 1684.92% to 41553000.0 in 2023, then plunged by 92.47% to 3129000.0 in 2024, then jumped by 1016.71% to 34942000.0 in 2025, then tumbled by 89.12% to 3802000.0 in 2026.
- The last three Liabilities from Discontinued Operations figures came in at 3802000.0 (Q1 2026), 34942000.0 (Q4 2025), and 37411000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Trulieve Cannabis | - | - | 170.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.80 Mn |
| Mar 31, 2026 | 3.80 Mn |
| Dec 31, 2025 | 34.94 Mn |
| Dec 31, 2025 | 34.94 Mn |
| Sep 30, 2025 | 37.41 Mn |
| Sep 30, 2025 | 37.41 Mn |
| Jun 30, 2025 | 35.36 Mn |
| Jun 30, 2025 | 35.36 Mn |
| Mar 31, 2025 | 37.70 Mn |
| Mar 31, 2025 | 37.70 Mn |
| Dec 31, 2024 | 3.13 Mn |
| Dec 31, 2024 | 3.13 Mn |
| Sep 30, 2024 | 3.46 Mn |
| Sep 30, 2024 | 3.46 Mn |
| Jun 30, 2024 | 40.18 Mn |
| Jun 30, 2024 | 40.18 Mn |
| Mar 31, 2024 | 3.05 Mn |
| Mar 31, 2024 | 3.05 Mn |
| Dec 31, 2023 | 41.55 Mn |
| Dec 31, 2023 | 41.55 Mn |